Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.32 - $15.6 $2,799 - $136,468
8,748 Added 2.94%
306,611 $92,000
Q2 2022

Aug 12, 2022

BUY
$0.56 - $1.25 $9,651 - $21,542
17,234 Added 6.14%
297,863 $171,000
Q1 2022

May 13, 2022

BUY
$0.86 - $1.86 $47,242 - $102,175
54,933 Added 24.34%
280,629 $331,000
Q4 2021

Feb 11, 2022

BUY
$1.64 - $3.13 $256,343 - $489,240
156,307 Added 225.26%
225,696 $370,000
Q3 2021

Nov 12, 2021

BUY
$2.67 - $5.09 $123,119 - $234,710
46,112 Added 198.1%
69,389 $199,000
Q2 2021

Aug 13, 2021

BUY
$2.02 - $7.64 $47,019 - $177,836
23,277 New
23,277 $116,000

About ReShape Lifesciences Inc.


  • Ticker RSLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,559,400
  • Market Cap $130M
  • Description
  • ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...
More about RSLS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.